Provectus issued a PR today related to Craig's presentation on October 4 at the MD Becker 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference.
As expected, Craig "...will discuss PV-10's immunologic potential in treating melanoma and other cancer indications including liver, pancreatic and colorectal cancer."
The event will be webcast.
No comments:
Post a Comment